Patient classification and diagnosis of pulmonary lesions
Patient characteristics . | No. patients . |
|---|---|
| Patients with unpreviously diagnosed B-NHL | 82 |
| Primary pulmonary lymphomas | 13 |
| MALT lymphomas | 10 |
| DLBCL | 3 |
| Nonlymphomatous pulmonary lesions | 63 |
| Diffuse interstitial pneumoniae | 35 |
| Fibrosis/BOOP/LIP/drug-induced | 16 |
| Associated with autoimmune disease | 13 |
| Granulomatosis/sarcoidosis | 6 |
| Infectious pneumoniae | 20 |
| Miscellaneous* | 8 |
| Undetermined diagnosis | 6 |
| Patients with previously diagnosed B-cell lymphoproliferative disorder† | 24 |
| Secondary pulmonary B-cell NHL | 9 |
| DLBCL | 2 |
| Mantle cell lymphoma | 1 |
| Follicular lymphoma | 1 |
| Diffuse small cell lymphoma | 4 |
| MALT lymphoma | 1 |
| Nonlymphomatous pulmonary lesions | 12 |
| Diffuse interstitial pneumoniae | — |
| Fibrosis/drug-induced | 5 |
| Infectious pneumoniae | 5 |
| Miscellaneous cancer | 2 |
| Undetermined diagnosis | 3 |
Patient characteristics . | No. patients . |
|---|---|
| Patients with unpreviously diagnosed B-NHL | 82 |
| Primary pulmonary lymphomas | 13 |
| MALT lymphomas | 10 |
| DLBCL | 3 |
| Nonlymphomatous pulmonary lesions | 63 |
| Diffuse interstitial pneumoniae | 35 |
| Fibrosis/BOOP/LIP/drug-induced | 16 |
| Associated with autoimmune disease | 13 |
| Granulomatosis/sarcoidosis | 6 |
| Infectious pneumoniae | 20 |
| Miscellaneous* | 8 |
| Undetermined diagnosis | 6 |
| Patients with previously diagnosed B-cell lymphoproliferative disorder† | 24 |
| Secondary pulmonary B-cell NHL | 9 |
| DLBCL | 2 |
| Mantle cell lymphoma | 1 |
| Follicular lymphoma | 1 |
| Diffuse small cell lymphoma | 4 |
| MALT lymphoma | 1 |
| Nonlymphomatous pulmonary lesions | 12 |
| Diffuse interstitial pneumoniae | — |
| Fibrosis/drug-induced | 5 |
| Infectious pneumoniae | 5 |
| Miscellaneous cancer | 2 |
| Undetermined diagnosis | 3 |
MALT indicates mucosa-associated lymphoid tissue; DLBCL, diffuse large B-NHL; BOOP, bronchiolitis obliterans organizing pneumonia; LIP, lymphoid interstitial pneumonitis; and —,.
Five cancer, 1 Hodgkin disease, 1 alveolar proteinosis, 1 Castleman disease.
Seven myeloma/monoclonal gammapathy, 8 DLBCL, 1 mantle cell lymphoma, 1 follicular lymphoma, 7 diffuse small cell lymphoma, 1 MALT lymphoma.